SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-127921
Filing Date
2016-10-13
Accepted
2016-10-13 08:02:41
Documents
6
Period of Report
2016-10-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v450427_8k.htm 8-K 54397
2 EXHIBIT 2.1 v450427_ex2-1.htm EX-2.1 541762
3 EXHIBIT 3.1 v450427_ex3-1.htm EX-3.1 4212
4 EXHIBIT 99.1 v450427_ex99-1.htm EX-99.1 41113
5 EXHIBIT 99.2 v450427_ex99-2.htm EX-99.2 41549
6 EXHIBIT 99.3 v450427_ex99-3.htm EX-99.3 19387
  Complete submission text file 0001144204-16-127921.txt   703738
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

IRS No.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36439 | Film No.: 161934081
SIC: 3826 Laboratory Analytical Instruments